These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34224639)

  • 1. In vitro metabolism of the REV-ERB agonist SR-9009 and subsequent detection of metabolites in associated routine equine plasma and urine doping control samples.
    Cutler C; White DL; Viljanto M
    Drug Test Anal; 2022 Jan; 14(1):169-174. PubMed ID: 34224639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of 'designer' steroids in the equine.
    Clarke A; Scarth J; Teale P; Pearce C; Hillyer L
    Drug Test Anal; 2011 Jan; 3(1):74-87. PubMed ID: 21322180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
    Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
    J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011.
    Geldof L; Deventer K; Roels K; Tudela E; Van Eeno P
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27706103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the metabolism of the selective androgen receptor modulator LGD-4033 in equine urine, plasma and hair following oral administration.
    Cutler C; Viljanto M; Hincks P; Habershon-Butcher J; Muir T; Biddle S
    Drug Test Anal; 2020 Feb; 12(2):247-260. PubMed ID: 31655494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo metabolism of the anabolic-androgenic steroid oxandrolone in the horse.
    Harding C; Viljanto M; Cutler C; Habershon-Butcher J; Biddle S; Scarth J
    Drug Test Anal; 2022 Jan; 14(1):39-55. PubMed ID: 34378336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine metabolism of the growth hormone secretagogue MK-0677 in vitro and in urine and plasma following oral administration.
    Cutler C; Viljanto M; Taylor P; Habershon-Butcher J; Van Eenoo P
    Drug Test Anal; 2022 Jul; 14(7):1273-1290. PubMed ID: 35302297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic studies of hypoxia-inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control.
    Philip M; Mathew B; Karatt TK; Perwad Z; Subhahar MB; Karakka Kal AK
    Drug Test Anal; 2021 Apr; 13(4):794-816. PubMed ID: 33458935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine metabolism of the selective androgen receptor modulator AC-262536 in vitro and in urine, plasma and hair following oral administration.
    Cutler C; Viljanto M; Taylor P; Habershon-Butcher J; Muir T; Biddle S; Van Eenoo P
    Drug Test Anal; 2021 Feb; 13(2):369-385. PubMed ID: 32959959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in equine anti-doping.
    Cawley A
    Drug Test Anal; 2017 Sep; 9(9):1282-1283. PubMed ID: 28631881
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of in vitro technologies coupled with high resolution accurate mass LC-MS for studying drug metabolism in equine drug surveillance.
    Scarth JP; Spencer HA; Timbers SE; Hudson SC; Hillyer LL
    Drug Test Anal; 2010 Jan; 2(1):1-10. PubMed ID: 20878880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
    Beuck S; Bornatsch W; Lagojda A; Schänzer W; Thevis M
    Drug Test Anal; 2011; 3(11-12):756-70. PubMed ID: 22213684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-throughput and broad-spectrum screening method for analysing over 120 drugs in horse urine using liquid chromatography-high-resolution mass spectrometry.
    Wong JKY; Chan GHM; Choi TLS; Kwok KY; Lau MY; Leung GNW; Wan TSM; Ho ENM
    Drug Test Anal; 2020 Jul; 12(7):900-917. PubMed ID: 32267632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the metabolites of the HIF stabilizer FG-4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry.
    Hansson A; Thevis M; Cox H; Miller G; Eichner D; Bondesson U; Hedeland M
    J Pharm Biomed Anal; 2017 Feb; 134():228-236. PubMed ID: 27918992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doping control analysis of 46 polar drugs in horse plasma and urine using a 'dilute-and-shoot' ultra high performance liquid chromatography-high resolution mass spectrometry approach.
    Kwok WH; Choi TLS; Kwok KY; Chan GHM; Wong JKY; Wan TSM
    J Chromatogr A; 2016 Jun; 1451():41-49. PubMed ID: 27180888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic study of GW1516 in equine urine using liquid chromatography/electrospray ionization Q-Exactive high-resolution mass spectrometry for doping control.
    Ishii H; Shibuya M; Leung GN; Yamashita S; Yamada M; Kushiro A; Kasashima Y; Okada J; Kawasaki K; Kijima-Suda I
    Rapid Commun Mass Spectrom; 2021 Mar; 35(5):e9028. PubMed ID: 33319421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid investigating of phase I metabolites of SR9009 in vitro horse liver microsomes via feature-based molecular networking approach: Potential applications in doping control.
    Kwak YB; Yoon J; Yoo HH
    J Pharm Biomed Anal; 2024 Aug; 246():116190. PubMed ID: 38735208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine in vivo metabolite profiling of the selective androgen receptor modulator LGD-3303 for doping control.
    Broberg MN; Knych H; Bondesson U; Pettersson C; Tidstedt B; Stanley S; Thevis M; Hedeland M
    J Pharm Biomed Anal; 2023 Sep; 233():115468. PubMed ID: 37224728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.